150 related articles for article (PubMed ID: 24347486)
1. Study of circulating antibodies against CD25 and FOXP3 in breast cancer.
Liu T; Song YN; Shi QY; Liu Y; Bai XN; Pang D
Tumour Biol; 2014 Apr; 35(4):3779-83. PubMed ID: 24347486
[TBL] [Abstract][Full Text] [Related]
2. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J
Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381
[TBL] [Abstract][Full Text] [Related]
3. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
4. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
[TBL] [Abstract][Full Text] [Related]
5. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma.
Ye L; Guan S; Zhang C; Lee KH; Sun S; Wei J; Liu B
Tumour Biol; 2013 Jun; 34(3):1873-7. PubMed ID: 23483489
[TBL] [Abstract][Full Text] [Related]
6. FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer.
Xu S; Huangfu M; Jia X; Song X; Sun B; Lee KH; Liu L; Sun S
Int J Clin Oncol; 2015 Oct; 20(5):982-8. PubMed ID: 25681877
[TBL] [Abstract][Full Text] [Related]
7. Significance of immunoregulatory T cells in different stages of breast cancer patients.
Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
[TBL] [Abstract][Full Text] [Related]
8. A study of circulating anti-CD25 antibodies in non-small cell lung cancer.
Ye L; Li X; Sun S; Guan S; Wang M; Guan X; Lee KH; Wei J; Liu B
Clin Transl Oncol; 2013 Aug; 15(8):633-7. PubMed ID: 23263913
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.
Liu S; Zhang X; Jiang Q; Liang T
FEBS Open Bio; 2020 Jul; 10(7):1288-1294. PubMed ID: 32392378
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile of CD4
Niakan A; Faghih Z; Talei AR; Ghaderi A
Mol Immunol; 2019 Dec; 116():90-97. PubMed ID: 31630080
[TBL] [Abstract][Full Text] [Related]
12. Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.
Wang J; Xu Y; Wang Y; Zhang X; Zhang G
Onco Targets Ther; 2019; 12():10487-10493. PubMed ID: 31819529
[TBL] [Abstract][Full Text] [Related]
13. Study of Circulating Natural Antibodies Against CD25 and FOXP3 in Type-2 Diabetes.
Qiu C; Li C; Wu X; Chen X; Zhang X; Meng Q
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776743
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
[TBL] [Abstract][Full Text] [Related]
15. Circulating Antibodies to Linear Peptide Antigens Derived from ANXA1 and FOXP3 in Lung Cancer.
Wang W; Zhong W; Chen C; Meng Q; Wei J
Anticancer Res; 2017 Jun; 37(6):3151-3155. PubMed ID: 28551657
[TBL] [Abstract][Full Text] [Related]
16. Decreased circulating CD4+CD25highFoxp3+ T cells during acute rejection in liver transplant patients.
He Q; Fan H; Li JQ; Qi HZ
Transplant Proc; 2011 Jun; 43(5):1696-700. PubMed ID: 21693260
[TBL] [Abstract][Full Text] [Related]
17. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.
Xu G; Mou Z; Jiang H; Cheng L; Shi J; Xu R; Oh Y; Li H
Laryngoscope; 2007 May; 117(5):876-80. PubMed ID: 17473687
[TBL] [Abstract][Full Text] [Related]
18. Expression of Th17 and CD4
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
[TBL] [Abstract][Full Text] [Related]
19. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]